CoChat

Cytokine release and its modulation by dexamethasone in whole blood following exercise

Open access
Smits, H H, Grünberg, K, Derijk, R H, Sterk, P J, Hiemstra, P S · 2001 · Clinical and Experimental Immunology
Cited by 54

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

SUMMARY: Glucocorticoids (GC) play an important role in the treatment of inflammatory diseases like asthma. However, in selected patients a relative resistance to GC has been reported. Recently, it has been suggested that GC sensitivity of peripheral blood leucocytes may be regulated in a dynamic fashion during exercise, in association with activation of the hypothalamic–pituitary–adrenal (HPA) axis. The aim of the present study was to explore changes in the GC sensitivity of cytokine production by leucocytes following strenuous exercise by well trained oarsmen. These changes were studied using lipopolysaccharide (LPS)-induced and anti-CD2/anti-CD28 MoAb-stimulated cytokine release in whole blood and its modulation by dexamethasone. Following exercise, significant decreases in LPS-induced release of IL-6, tumour necrosis factor-alpha (TNF-α) and IL-10 and anti-CD2/anti-CD28 MoAb-stimulated secretion of interferon-gamma (IFN-γ) were observed. In addition, the inhibitory effect of dexamethasone on both IL-6 and TNF-α secretion was significantly reduced following exercise, whereas that on IL-10 and IFN-γ release was not affected. These exercise-induced changes were accompanied by activation of the HPA axis, as indicated by an increase in circulating adrenocorticotropic hormone (ACTH) levels immediately following exercise. The results from the present study suggest that GC sensitivity of whole blood cytokine release can be regulated in a dynamic fashion and that this can be assessed using an ex vivo stimulation assay. Moreover, since dexamethasone responsiveness of anti-CD2/anti-CD28 MoAb-induced IFN-γ secretion in whole blood is not affected by exercise, it may suggest that exercise differentially affects monocytes and lymphocytes. The dynamic regulation of steroid responsiveness of leucocytes, as observed in the present study, could have important consequences for the effectiveness of GC treatment in inflammatory diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2249.1998.00482.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 32

  1. Schwiebert, 1996, Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions, J Allergy Clin Immunol, 97, 143, 10.1016/S0091-6749(96)80214-4 · DOI · Paper page
  2. Abbinante-Nissen, 1995, Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells, Am J Physiol, 12, L601
  3. Van Furth, 1995, Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor-necrosis factor alpha, interleukin-1 beta (IL-1 beta), and IL-10 by human leukocytes, Clin Diagn Lab Immunol, 2, 689, 10.1128/cdli.2.6.689-692.1995 · DOI
  4. Cypcar, 1993, Steroid-resistant asthma, J Allergy Clin Immunol, 92, 362, 10.1016/0091-6749(93)90114-U · DOI
  5. Kirkham, 1991, Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell-mediated immune assay predicts in vivo response, J Rheumatol, 18, 1130
  6. Corrigan, 1991, Glucocorticoid resistance in chronic asthma: glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro, Am Rev Res Dis, 144, 101
  7. Spahn, 1996, Effects of glucocorticoids on lymphocyte activation in patients with steroid-sensitive and steroid-resistant asthma, J Allergy Clin Immunol, 98, 1073, 10.1016/S0091-6749(96)80194-1 · DOI
  8. Nijhuis, 1994, Decreased sensitivity to dexamethasone in lymphocytes from patients with Alzheimer's disease, Clin Immunol Immunopathol, 73, 45, 10.1006/clin.1994.1168 · DOI
  9. Adcock, 1995, Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma, J Immunol, 154, 3500, 10.4049/jimmunol.154.7.3500 · DOI · Paper page
  10. Rosewicz, 1988, Mechanism of glucocorticoid receptor down-regulation by glucocorticoids, J Biol Chem, 263, 2581, 10.1016/S0021-9258(18)69104-5 · DOI · Paper page
  11. Korn, 1997, In vitro and in vivo modulation of α- and β-glucocorticoidreceptor mRNA in human bronchial epithelium, Am J Resp Crit Care Med, 155, 1117, 10.1164/ajrccm.155.3.9116996 · doi:10.1164/ajrccm.155.3.9116996
  12. DeRijk, 1996, Changes in corticosteroid sensitivity of peripheral blood lymphocytes after strenuous exercise in humans, J Clin Endo Metabol, 81, 228
  13. Sauer, 1995, The glucocorticoid sensitivity of lymphocytes changes according to the activity of the hypothalamic–pituitary–adrenocortical system, Psychoneuroendocrinol, 20, 269, 10.1016/0306-4530(94)00058-I · DOI
  14. Brown, 1993, Regulation of mycobacterial growth by the hypothalamus–pituitary–adrenal axis: differential responses of Mycobacterium bovis BCC-resistant and -susceptible mice, Infect Immun, 61, 4793, 10.1128/iai.61.11.4793-4800.1993 · DOI
  15. Dunn, 1994, Neurochemical and neuroendocrine responses to Newcastle disease virus administration in mice, Brain Res, 645, 103, 10.1016/0006-8993(94)91643-8 · DOI
  16. Barnes, 1996, Mechanisms of action of glucocorticoids in asthma, Am J Resp Crit Care Med, 154, S21, 10.1164/ajrccm/154.2_Pt_2.S21 · DOI
  17. Brattsand, 1996, Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies, Aliment Pharmacol, 10, 81, 10.1046/j.1365-2036.1996.22164025.x · DOI · Paper page
  18. DeRijk, 1997, Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNFα) productions in humans: high sensitivity of TNFα and resistance of IL-6, J Clin Endo Metabol, 82, 2182
  19. Ertel, 1995, Downregulation of proinflammatory cytokine release in whole blood from septic patients, Blood, 85, 1341, 10.1182/blood.V85.5.1341.bloodjournal8551341 · DOI · Paper page
  20. Kremer, 1996, Interleukin-1, -6 and tumor necrosis factor-α release is down-regulated in whole blood from septic patients, Acta Haematol, 95, 268, 10.1159/000203895 · doi:10.1159/000203895
  21. Fischer, 1995, Selective suppression of cytokine secretion in patients with small-cell lung cancer, Anal Oncol, 6, 921, 10.1093/oxfordjournals.annonc.a059360 · doi:10.1093/oxfordjournals.annonc.a059360
  22. Dinarello, 1991, Interleukin-1 and interleukin-1 antagonism, Blood, 77, 1627, 10.1182/blood.V77.8.1627.1627 · DOI · Paper page
  23. Van der Pouw-Kraan, 1992, Interleukin (IL)-4 production by human T cells: differential regulation of IL-4 vs. IL-2 production, Eur J Immunol, 22, 1237, 10.1002/eji.1830220519 · DOI · Paper page
  24. Grbic, 1991, The role of prostaglandin E2 in immune suppression following injury, Ann Surg, 214, 253, 10.1097/00000658-199109000-00008 · DOI · Paper page
  25. Gearing, 1994, Processing of tumour necrosis factor-α precursor by metalloproteinases, Nature, 370, 555, 10.1038/370555a0 · DOI · Paper page
  26. McGeehan, 1994, Regulation of tumour necrosis factor-α processing by metalloproteinase inhibitor, Nature, 370, 558, 10.1038/370558a0 · DOI · Paper page
  27. Nijhuis, 1994, Abrogation of the suppressive effects of dexamethasone by PKC activation or CD28 triggering, Cell Immunol, 156, 438, 10.1006/cimm.1994.1188 · DOI
  28. Kavelaars, 1995, Increased dexamethasone sensitivity of neonatal leukocytes: different mechanisms of glucocorticoid inhibition of T cell proliferation in adult and neonatal cells, Eur J Immunol, 25, 1346, 10.1002/eji.1830250532 · DOI
  29. Kam, 1993, Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids, J Immunol, 151, 346, 10.4049/jimmunol.151.7.3460 · DOI · Paper page
  30. Bamberger, 1996, Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids, Endoc Rev, 17, 245, 10.1210/edrv-17-3-245 · DOI · Paper page
  31. Espersen, 1990, Effect of physical exercise on cytokines and lymphocyte subpopulations in human peripheral blood, APMIS, 98, 395, 10.1111/j.1699-0463.1990.tb01049.x · DOI · Paper page
  32. Field, 1991, Circulating mononuclear cell numbers and function during intense exercise and recovery, J Appl Physiol, 71, 1089, 10.1152/jappl.1991.71.3.1089 · DOI

Cited by

See all 54

Metadata

Authors
Smits, H. H., Grünberg, K., Derijk, R. H., Sterk, P. J., & Hiemstra, P. S.
Venue
Clinical and Experimental Immunology
Published
1998-02
Volume
111
Issue
2
Pages
463-468
ISSN
  • 0009-9104 (ISSN-L)
  • 1365-2249
OpenAlex
W2011637488
Cited by
54
References
2
FWCI
3.23
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cytokine release and its modulation by dexamethasone in whole blood following exercise. https://app.cochat.ai/papers/10.1046/j.1365-2249.1998.00482.x
The paper
Smits, H. H., Grünberg, K., Derijk, R. H., Sterk, P. J., & Hiemstra, P. S. (2001). Cytokine release and its modulation by dexamethasone in whole blood following exercise. Clinical and Experimental Immunology. https://doi.org/10.1046/j.1365-2249.1998.00482.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.